Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Most provincial and private health insurance plans do not cover semaglutide in all circumstances
Strong plaintiff verdicts push defendants toward settlement
Presented for research literature review only Zhou MS et al
Like Ozempic, Wegovy is also manufactured by Novo Nordisk and contains semaglutide
In addition to testosterone replacement therapy, we may suggest paired treatments to boost your overall health based on the results from your lab work
DESCRIPTION TABLE OF CONTENTS METHODOLOGY DOWNLOAD PDF GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, tirzepatide), Type (Patented, Biosimilars), Format (Single dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033 USD 170.75 BN MARKET SIZE, 2033 OVERVIEW Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis The global GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period
